Patients Start early - live well: Addressing the mental health crisis According to the World Health Organization (WHO), globally, one in seven 10-19-year-olds experiences a mental disorder, accounting for
Patients Keeping stigma out of it: Personalising the mental health co... Thursday 10th October was World Mental Health Day, focused this year on ‘mental health at work’.
R&D Neuroplastogens: A novel approach to treat neurological dise... In the US alone, one in five adults experiences a form of mental illness each year. New medicines are urgently needed, as current therapies fail to work in up to a third of patients.
Views & Analysis Progress in mental health digital innovation What new digital technologies are being introduced to help reduce mental illness?
News Dizal set to bring lung cancer drug Zegfrovy to US Dizal gets US approval for an oral therapy for EGFR exon 20-mutated NSCLC, offering some patients an alternative to J&J's intravenous Rybrevant.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face